The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy
Open Access
- 1 January 2018
- journal article
- research article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (1), 65-70
- https://doi.org/10.2169/internalmedicine.9013-17
Abstract
One adverse effect of methylprednisolone (MP) pulse therapy is an acute dose- dependent increase in the blood glucose level. Five patients with thyroid ophthalmopathy but normal glucose tolerance received MP pulse therapy (3 cycles, 3 days/week) and were assessed by continuous glucose monitoring. Steroid therapy increased the mean sensor glucose level, and all patients developed steroid-induced diabetes. The patients were treated alternately with mitiglinide (30 mg/day) and repaglinide (1.5 mg/day) during the second or third MP pulse therapy. The sensor glucose levels before lunch and dinner were more favorable during treatment with repaglinide than during treatment with mitiglinide. Repaglinide may be more clinically appropriate than mitiglinide.Keywords
This publication has 18 references indexed in Scilit:
- Glucose disturbances in non-diabetic patients receiving acute treatment with methylprednisolone pulsesRevista da Associação Médica Brasileira, 2012
- RepaglinideDrugs, 2012
- Glucocorticoid-induced diabetes and adrenal suppression: How to detect and manage themCleveland Clinic Journal of Medicine, 2011
- Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed Type 2 Diabetes MellitusDiabetes Research and Clinical Practice, 2010
- Multicentre, Double-blind, Randomized Study of Mitiglinide Compared with Nateglinide in Type 2 Diabetes Mellitus Patients in ChinaJournal of International Medical Research, 2009
- Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusionThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patientsExpert Opinion on Pharmacotherapy, 2008
- The epidemiology of glucocorticoid-associated adverse eventsCurrent Opinion in Rheumatology, 2008
- Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.JCI Insight, 1997
- Influence of Glucocorticoids on Glucagon Secretion and Plasma Amino Acid Concentrations in ManJCI Insight, 1973